Annual Drug Patent Expirations for LUPRON+DEPOT
Lupron Depot is a drug marketed by Abbvie Endocrine Inc and is included in five NDAs. It is available from one supplier. There are two patents protecting this drug.
LUPRON DEPOT drug price trends.
This drug has ninety-six patent family members in forty-one countries.
The generic ingredient in LUPRON DEPOT is leuprolide acetate. One supplier is listed for this compound. Additional details are available on the leuprolide acetate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com